JP2022521446A5 - - Google Patents
Info
- Publication number
- JP2022521446A5 JP2022521446A5 JP2021572257A JP2021572257A JP2022521446A5 JP 2022521446 A5 JP2022521446 A5 JP 2022521446A5 JP 2021572257 A JP2021572257 A JP 2021572257A JP 2021572257 A JP2021572257 A JP 2021572257A JP 2022521446 A5 JP2022521446 A5 JP 2022521446A5
- Authority
- JP
- Japan
- Prior art keywords
- intravenous formulation
- formulation according
- fenfluramine
- patient
- syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962810228P | 2019-02-25 | 2019-02-25 | |
| US62/810,228 | 2019-02-25 | ||
| PCT/US2020/018359 WO2020176276A1 (en) | 2019-02-25 | 2020-02-14 | A formulation for improving seizure control |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022521446A JP2022521446A (ja) | 2022-04-07 |
| JP2022521446A5 true JP2022521446A5 (cg-RX-API-DMAC10.html) | 2022-12-07 |
Family
ID=72239800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021572257A Pending JP2022521446A (ja) | 2019-02-25 | 2020-02-14 | 発作制御を改善するための製剤 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220133652A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3930841A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2022521446A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2020176276A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220044380A (ko) | 2013-04-12 | 2022-04-07 | 이칸 스쿨 오브 메디슨 엣 마운트 시나이 | 외상후 스트레스 장애의 치료 방법 |
| US9549909B2 (en) | 2013-05-03 | 2017-01-24 | The Katholieke Universiteit Leuven | Method for the treatment of dravet syndrome |
| DK3800177T3 (da) | 2015-12-22 | 2025-03-31 | Zogenix International Ltd | Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme |
| US10689324B2 (en) | 2015-12-22 | 2020-06-23 | Zogenix International Limited | Metabolism resistant fenfluramine analogs and methods of using the same |
| RU2021106383A (ru) | 2016-08-24 | 2021-04-05 | Зодженикс Интернэшнл Лимитед | Состав для ингибирования образования агонистов 5-ht2b и способы его применения |
| US10682317B2 (en) | 2017-09-26 | 2020-06-16 | Zogenix International Limited | Ketogenic diet compatible fenfluramine formulation |
| CA3097335A1 (en) | 2018-05-11 | 2019-11-14 | Zogenix International Limited | Compositions and methods for treating seizure-induced sudden death |
| WO2020105005A1 (en) | 2018-11-19 | 2020-05-28 | Zogenix International Limited | Methods of treating rett syndrome using fenfluramine |
| US11612574B2 (en) | 2020-07-17 | 2023-03-28 | Zogenix International Limited | Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| GB2597323A (en) * | 2020-07-20 | 2022-01-26 | Gw Res Ltd | Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities |
| US20240197704A1 (en) * | 2021-04-09 | 2024-06-20 | Johns Hopkins University | Treatment methods and compositions comprising perampanel |
| EP4351727A4 (en) * | 2021-05-28 | 2025-01-01 | Icahn School of Medicine at Mount Sinai | METHOD OF TREATMENT OF DRUG-RESISTANT EPILEPSY |
| US12667723B2 (en) | 2022-04-08 | 2026-06-30 | Patrick M. Nemechek | Systems and methods for treating autism spectrum disorder, developmental disorders and other medical conditions |
| CN117530933B (zh) * | 2024-01-10 | 2024-05-10 | 江苏长泰药业股份有限公司 | 一种吡仑帕奈长效缓释微球、制备方法及缓释注射剂 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0410266D0 (en) * | 2004-05-07 | 2004-06-09 | Ketocytonyx Inc | Treatment of apoptosis |
| EP2355818A4 (en) * | 2008-10-10 | 2012-04-11 | Us Of America As Represented By The Secretary Of The Army On Behalf Of Walter Reed Army Inst Of Res | METHOD AND COMPOSITIONS FOR TREATING THE STATUS EPILEPTICUS AND STATUS EPILEPTICUS CAUSING ATTACHMENTS |
| US9549909B2 (en) * | 2013-05-03 | 2017-01-24 | The Katholieke Universiteit Leuven | Method for the treatment of dravet syndrome |
| JP2018504420A (ja) * | 2015-02-06 | 2018-02-15 | マリナス ファーマシューティカルズ インコーポレイテッド | 静注用ガナキソロン製剤ならびにてんかん重積状態および他の発作性障害の治療におけるその使用 |
| KR102615486B1 (ko) * | 2015-08-24 | 2023-12-19 | 조게닉스 인터내셔널 리미티드 | 펜플루라민을 사용하여 레녹스-가스토 증후군을 치료하는 방법 |
-
2020
- 2020-02-14 WO PCT/US2020/018359 patent/WO2020176276A1/en not_active Ceased
- 2020-02-14 JP JP2021572257A patent/JP2022521446A/ja active Pending
- 2020-02-14 EP EP20762650.8A patent/EP3930841A4/en not_active Withdrawn
- 2020-02-14 US US17/430,033 patent/US20220133652A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022103194A (ja) | S1p受容体アゴニストの投与レジメン | |
| Bryson et al. | Individualized anesthetic management for patients undergoing electroconvulsive therapy: a review of current practice | |
| US9913833B2 (en) | Methods of treating developmental disorders using pipradrol | |
| EP3930841A1 (en) | A formulation for improving seizure control | |
| JP2006117689A (ja) | 置換フェネチルアミン類を用いた医薬組成物 | |
| TW202002971A (zh) | 治療疼痛的方法 | |
| TW200918077A (en) | Compositions and methods employing NMDA antagonists for achieving an anesthetic-sparing effect | |
| WO2008116890A2 (en) | Pharmaceutical compositions comprising flibanserin and a further agent in the treatment of sexual disorders | |
| US20100227916A1 (en) | N-desmethyl-doxepin and methods of using the same to treat sleep disorders | |
| TWI304735B (en) | Carbamate compounds for use in the treatment of pain | |
| EA013591B1 (ru) | Применение пептидных соединений для профилактики, облегчения и лечения головной боли и болезненных состояний, связанных с или вызванных распространяющейся кортикальной депрессией (csd) | |
| JP2021152060A (ja) | アカンプロセートおよびd−サイクロセリンを使用する組み合わせ療法 | |
| JP2023526517A (ja) | 運動失調症を治療するためのアセチルロイシンと4-アミノピリジン又はアセタゾラミドとの組合せ | |
| WO2002064213A1 (es) | Empleo de flumazenilo en la elaboracion de un medicamento para el tratamiento de la dependencia de cocaina | |
| CN101636391A (zh) | 神经病理性疼痛的新型预防剂和/或治疗剂 | |
| RU2120283C1 (ru) | Способ лечения эпилепсии | |
| US20230000796A1 (en) | Intranasal administration of ketamine to cluster headache patients | |
| RU2227028C1 (ru) | Способ лечения невралгии тройничного нерва | |
| US11364218B2 (en) | Method of treating or preventing mood disorders, mental disorders, and/or chronic fatigue syndrome | |
| JP2024502466A5 (cg-RX-API-DMAC10.html) | ||
| Adkoli | Symptomatic hyponatremia in patients on oxcarbazepine therapy for the treatment of neuropathic pain: two case reports | |
| JP2021509671A5 (cg-RX-API-DMAC10.html) | ||
| Bacon et al. | NONVERBAL AUTISTIC 30-YEAR-OLD FOR FULL MOUTH DENTAL REHABILITATION WITH MALIGNANT HYPERTHERMIA | |
| RU2641163C1 (ru) | Способ лечения устойчивых пароксизмальных состояний и генерализованных миоклоний у пациентов с последствиями тяжелого поражения головного мозга | |
| JP2017088584A (ja) | 医薬組成物 |